Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Aug 5:14:100024.
doi: 10.1016/j.jarlif.2025.100024. eCollection 2025.

Alterations of the oral microbiota in mild Alzheimer's disease and the appropriate application of chlorhexidine gluconate

Affiliations

Alterations of the oral microbiota in mild Alzheimer's disease and the appropriate application of chlorhexidine gluconate

Huizhen Cao et al. JAR Life. .

Abstract

Objective: This study investigated the effect of 0.2 % chlorhexidine gluconate on oral microbiota dysbiosis in Alzheimer's disease (AD) and explored potential links between oral microbiota and cognition, offering new insights into its role in AD treatment.

Study design: We assessed the impact of 0.2 % chlorhexidine gluconate on the oral microbiota of patients with AD. One hundred patients were divided into two groups based on oral health score (using a cut-off of 8). Subgingival plaque samples were analyzed using 16S rRNA sequencing; no significant differences in bacterial composition were observed between groups at baseline.

Results: Poor oral health correlated with higher oral health scores (P = 0.000), fewer teeth (P = 0.002), lower cognitive levels (P = 0.048), and a higher proportion of patients with diabetes (P = 0.032). After 24 weeks of treatment with 0.2 % chlorhexidine gluconate in a randomized controlled trial, subgingival plaques from 66 patients showed changes in Porphyromonas, Filifactor, Desulfobulbus, Anaeroglobus, Pyramidobacter, Mycoplasma, Dialister, Fretibacterium, and Tannerella (P < 0.05). Treponema and Porphyromonas gingivalis were identified as potential interventional targets.

Conclusion: Chlorhexidine gluconate effectively alters oral flora, reducing harmful bacteria. Targeting specific microbiota disturbances may offer a promising strategy to delay AD onset or slow its progression.

Trial registration: This research was registered with the Chinese Clinical Trial Registry (ChiCTR; Reference: ChiCTR2000032876). Registered: 14th of May 2020; http://www.chictr.org.cn/showprojen.aspx?proj=53555.

Keywords: 16S rRNA; Alzheimer’s disease; Chlorhexidine gluconate; Neuroinflammation; Oral microbiota.

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Figures

Fig 1
Fig. 1
Study design.Pre- and post-randomized controlled trial (RCT). The measurements were performed before and after intervention.
Fig 2
Fig. 2
Comparison of the preintervention oral microbiome of BOHSE≤8 and BOHSE>8 groups. (A) PCoA of oral microbiota in BOHSE≤8 and BOHSE>8 samples. (B) Heatmap of relative abundance between BOHSE≤8 and BOHSE>8 groups at the genus level.
Fig 3
Fig. 3
Comparison of the postintervention oral microbiome of intervention and control groups. (A) Balloon plot showing the results of the oral microbiota in intervention and control groups.(B) Shepard plot and NMDS plot of oral microbiota in intervention and control groups.(C) Extended error bar plot illustrating genera statistically different between intervention and control groups.

Similar articles

References

    1. Global, regional, and national burden of disorders affecting the nervous system, 1990-2021: a systematic analysis for the Global Burden of Disease Study 2021. Lancet Neurol. 2024;23(4) - PMC - PubMed
    1. Alzheimer's disease facts and figures. Alzheimer Dement. 2024;2024
    1. Chenshuang L., Lingling W., Lieyun D., et al. Determinants and inequities in healthy working life expectancy in China. Nat Med. 2024;(0) - PubMed
    1. Michael T H., Monica J C., Joseph E.K., et al. Neuroinflammation in Alzheimer's disease. Lancet Neurol. 2015;14 - PMC - PubMed
    1. Yongwang L., Xiaoyue L., Zhengyi L., et al. Omics for deciphering oral microecology. Int J Oral Sci. 2024;16 - PMC - PubMed

LinkOut - more resources